22.02.2022 • NewsSolvay

Solvay expands US-based Sulfone Polymers Output

Belgian chemicals and plastics giant Solvay is expanding its US portfolio of sulfone products to meet growing demand from what it says is a growing global base for polymer solutions for various in critical life science applications.

Solvay said the multi-year expansion plan will include capacity increases for nearly all of its sulfone products, including its Udel-branded polysulfones (PSU), Veradel polyether sulfones (PESU) and Radel polyphenyl sulfones (PPSU). In the first major investment step, output capability of PSU will rise by more than 25% by 2024 at the company’ US s site in Marietta, Ohio. The bulk will be completed by early 2023.

Production of dichlorodiphenyl sulfone (DCDPS), a key building block for an important common building block for all sulfone polymers, will be expanded by more than 25%, with new capacity at the Augusta, Georgia, coming on stream by end of 2022.

Key application market segment benefiting from the investments are to include hemodialysis, medical instruments and pharmaceuticals in both development and production, and water purification. Here the company expects strong double-digit growth in global demand, with the high-performance sulfone polymers also playing a growing role in residential and commercial heating and plumbing systems.

The capacity upgrades, which Carmelo Lo Faro, president of Solvay's Materials segment, says are an important step in Solvay’s strategy for future growth affirm its number one position in the US sulfone polymers market are aimed at addressing the growth potential of the products in high-performance life-saving and life-sustaining areas, such as healthcare, water purification and pharmaceutical processing.

Author: Dede Williams, Freelance Journalist

(c) Solvay
(c) Solvay

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.